ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

In Brief: Disapproved CCP Wins Appeal; New Review; Trish Greene Named ACS VP For Nursing

February 26, 1988

NCI Still Supporting Construction Grants Despite Big Cuts

February 20, 1981

The President’s Cancer Panel publishes its annual report

May 6, 2011

Gene Expression Data Posted On Web For Research Use.

March 17, 2000